IDEXX Operating Income from 2010 to 2026
| IX1 Stock | EUR 555.60 1.20 0.22% |
Operating Income | First Reported 2016-12-31 | Previous Quarter 373 M | Current Value 354.8 M | Quarterly Volatility 80.5 M |
Check IDEXX Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among IDEXX Laboratories' main balance sheet or income statement drivers, such as Interest Expense of 24 M, Selling General Administrative of 765.7 M or Total Revenue of 2.8 B, as well as many indicators such as . IDEXX financial statements analysis is a perfect complement when working with IDEXX Laboratories Valuation or Volatility modules.
IDEXX | Operating Income |
The Operating Income trend for IDEXX Laboratories offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether IDEXX Laboratories is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest IDEXX Laboratories' Operating Income Growth Pattern
Below is the plot of the Operating Income of IDEXX Laboratories over the last few years. Operating Income is the amount of profit realized from IDEXX Laboratories operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of IDEXX Laboratories is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. It is earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations. IDEXX Laboratories' Operating Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in IDEXX Laboratories' overall financial position and show how it may be relating to other accounts over time.
| Operating Income | 10 Years Trend |
|
Operating Income |
| Timeline |
IDEXX Operating Income Regression Statistics
| Arithmetic Mean | 601,548,674 | |
| Geometric Mean | 512,302,880 | |
| Coefficient Of Variation | 58.42 | |
| Mean Deviation | 300,134,087 | |
| Median | 491,335,000 | |
| Standard Deviation | 351,432,805 | |
| Sample Variance | 123505T | |
| Range | 1B | |
| R-Value | 0.89 | |
| Mean Square Error | 27560.4T | |
| R-Squared | 0.79 | |
| Slope | 61,887,677 | |
| Total Sum of Squares | 1976080.3T |
IDEXX Operating Income History
About IDEXX Laboratories Financial Statements
IDEXX Laboratories stakeholders use historical fundamental indicators, such as IDEXX Laboratories' Operating Income, to determine how well the company is positioned to perform in the future. Although IDEXX Laboratories investors may analyze each financial statement separately, they are all interrelated. For example, changes in IDEXX Laboratories' assets and liabilities are reflected in the revenues and expenses on IDEXX Laboratories' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in IDEXX Laboratories. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Operating Income | 1.3 B | 713.6 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of IDEXX Laboratories Correlation against competitors. For more detail on how to invest in IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.